HESG (Health Sciences Group) Total Stockholders Equity: $-4.70 Mil (As of Sep. 2006)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Health Sciences Group Total Stockholders Equity?

Health Sciences Group HESG -99.00% Total Stockholders Equity is $-4.70 Mil as of Sep. 2006.

Health Sciences Group's Total Stockholders Equity for the quarter that ended in Sep. 2006 was $-4.70 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Health Sciences Group's Book Value per Share for the quarter that ended in Sep. 2006 was $-0.08. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Health Sciences Group's Debt-to-Equity for the quarter that ended in Sep. 2006 was -0.09.


Health Sciences Group  (OTCPK:HESG) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Health Sciences Group's Book Value per Share for the quarter that ended in Sep. 2006 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Health Sciences Group's Debt-to-Equity for the quarter that ended in Sep. 2006 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Health Sciences Group Total Stockholders Equity Related Terms


Health Sciences Group Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Health Sciences Group's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Health Sciences Group Total Stockholders Equity Chart

Health Sciences Group Annual Data
Trend Dec00 Dec01 Dec02 Dec03 Dec04 Dec05
Total Stockholders Equity
Get a 7-Day Free Trial 4.98 4.47 0.98 -6.12 -4.91

Health Sciences Group Quarterly Data
Dec01 Mar02 Jun02 Sep02 Dec02 Mar03 Jun03 Sep03 Dec03 Mar04 Jun04 Sep04 Dec04 Mar05 Jun05 Sep05 Dec05 Mar06 Jun06 Sep06
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.14 -4.91 -4.40 -4.49 -4.70
What does a Total Stockholders Equity of $-4.70 Mil mean?
Health Sciences Group (HESG) has a Total Stockholders Equity of $-4.70 Mil as of Sep. 2006. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Health Sciences Group and its competitors.
Is Health Sciences Group's Total Stockholders Equity too high?
Health Sciences Group's current Total Stockholders Equity is $-4.70 Mil.
How does Health Sciences Group's Total Stockholders Equity compare to VITIF and HSTC?
Health Sciences Group's Total Stockholders Equity of $-4.70 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Biotechnology company?
A good Total Stockholders Equity depends on the Biotechnology industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Health Sciences Group and its competitors. Health Sciences Group's current Total Stockholders Equity is $-4.70 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Health Sciences Group stock overvalued right now?
Health Sciences Group (HESG) has a current Total Stockholders Equity of $-4.70 Mil. The current Total Stockholders Equity is $-4.70 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Health Sciences Group (HESG), the current Total Stockholders Equity is $-4.70 Mil as of Sep. 2006. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Health Sciences Group Business Description

Address 14331 Euclid Street, Suite 207, Garden Grove, CA, USA, 92843
Health Sciences Group Inc identifies, develops, and commercializes nutritional products. Its products are targeted towards consumers and medical professionals interested in preventative healthcare alternatives. The products are sold as nutritional supplements and functional ingredients to retail and wholesale customers in the nutrition, skin care, and food industries. The company distributes its products under the Swiss Research and Swiss Diet brand names.